ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Novasep, a Pompey, France-based maker of active pharmaceutical ingredients and purification technologies, has expanded its bioprocess development services through the acquisition of Henogen. Spun out of the Free University of Brussels in 2000, Henogen brings upstream bioprocessing capabilities and has experience making recombinant proteins in a range of hosts, including bacteria, yeast, and insect and mammalian cells. Financial terms of the deal were not revealed, but Henogen has more than 100 employees and two biomanufacturing sites south of Brussels.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X